- UK Approves Oxford/AstraZeneca COVID-19 Vaccine
Britain approved a COVID-19 vaccine developed by Oxford University and AstraZeneca on Wednesday, which was hailed by Prime Minister Boris Johnson as “a triumph for British science.” The government said it had accepted the recommendation from the Medicines and Healthcare Products Experts at the MHRA concluded that the vaccine had met its strict standards of […]
- ‘No Final Diagnosis’ Yet for Ill COVID-19 Vaccine Recipient: AstraZeneca
AstraZeneca said on Sept. 9 that there is “no final diagnosis” for the single COVID-19 vaccine trial participant who has developed a “potentially unexplained” illness, causing the company to temporarily halt for the second time its late-stage Phase Three trial for its vaccine candidate. A spokesperson for the company said in a statement Wednesday that reports claiming […]
- Vaccine Will Be Distributed to All 64 Jurisdictions Within 24 Hours of FDA Approval: HHS
Top health officials told reporters at a Tuesday briefing on the Trump administration’s Operation Warp Speed initiative that a COVID-19 vaccine will be distributed to all of the nation’s 64 jurisdictions within 24 hours of approval by the Food and Drug Administration (FDA). Health and Human Services Secretary Alex Azar said at the briefing that […]
- AstraZeneca Resumes COVID-19 Vaccine Trial in US
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday. AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious neurological […]
- Australian Government Indemnifies COVID Vaccine Against Lawsuits
The Australian government will indemnify drug manufacturers against legal action for any adverse side-effects caused by the COVID-19 vaccine, which is currently undergoing trials. The government has decided against implementing a no-fault compensation scheme to cover any potential claims from patients experiencing side-effects from the new drug, according to a statement issued by the Department […]